Literature DB >> 23599174

Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema.

Carl W Baker, Talat Almukhtar, Neil M Bressler, Adam R Glassman, Sandeep Grover, Stephen J Kim, Timothy J Murtha, Michael E Rauser, Cynthia Stockdale.   

Abstract

IMPORTANCE: The incidence of development or worsening of macular edema (ME) is variable in eyes without diabetic ME (DME) undergoing cataract surgery.
OBJECTIVE: To estimate the incidence of central-involved ME 16 weeks following cataract surgery in eyes with diabetic retinopathy without definite central-involved DME preoperatively. DESIGN, SETTING, AND PARTICIPANTS: In a multicenter, prospective, observational study, 293 participants with diabetic retinopathy without definite central subfield thickening on optical coherence tomography (OCT) underwent cataract surgery. EXPOSURE: Cataract extraction surgery performed within 28 days of enrollment of eyes without DME in individuals with diabetes mellitus. MAIN OUTCOMES AND MEASURES: Development of central-involved ME defined as the following: (1) OCT central subfield thickness of 250 μm or greater (time-domain OCT) or 310 μm or greater (spectral-domain OCT) with at least a 1-step increase in logOCT central subfield thickness preoperatively to the 16-week visit; (2) at least a 2-step increase in logOCT central subfield thickness preoperatively to the 16-week visit; or (3) nontopical treatment for ME received before the 16-week visit with either of the OCT criteria met at the time of treatment.
RESULTS: The median participant age was 65 years. The median visual acuity letter score was 69 letters (Snellen equivalent 20/40). Forty-four percent of eyes had a history of treatment for DME. Sixteen weeks postoperatively, central-involved ME was noted in 0% (95% CI, 0%-20%) of 17 eyes with no preoperative DME. Of eyes with non-central-involved DME, 10% (95% CI, 5%-18%) of 97 eyes without central-involved DME and 12% (95% CI, 7%-19%) of 147 eyes with possible central-involved DME at baseline progressed to central-involved ME. History of DME treatment was significantly associated with central-involved ME development (P < .001). CONCLUSIONS AND RELEVANCE: In eyes with diabetic retinopathy without concurrent central-involved DME, presence of non-central-involved DME immediately prior to cataract surgery or history of DME treatment may increase the risk of developing central-involved ME 16 weeks after cataract extraction.

Entities:  

Mesh:

Year:  2013        PMID: 23599174      PMCID: PMC4142425          DOI: 10.1001/jamaophthalmol.2013.2313

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  16 in total

1.  Incidence of cystoid macular edema after uncomplicated phacoemulsification.

Authors:  Jale Mentes; Tansu Erakgun; Filiz Afrashi; Gokhan Kerci
Journal:  Ophthalmologica       Date:  2003 Nov-Dec       Impact factor: 3.250

2.  Macular edema and visual outcome following cataract surgery in patients with diabetic retinopathy and controls.

Authors:  Urban Eriksson; Albert Alm; Gunilla Bjärnhall; Elisabet Granstam; Anna Wikberg Matsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-09       Impact factor: 3.117

3.  Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Authors:  B E Klein; R Klein; S E Moss
Journal:  Am J Ophthalmol       Date:  1995-03       Impact factor: 5.258

4.  Factors affecting visual outcomes after small-incision phacoemulsification in diabetic patients.

Authors:  Mamta D Somaiya; Jason D Burns; Roni Mintz; Robert E Warren; Tatsuo Uchida; Bernard F Godley
Journal:  J Cataract Refract Surg       Date:  2002-08       Impact factor: 3.351

5.  Prevalence of cataracts in a population-based study of persons with diabetes mellitus.

Authors:  B E Klein; R Klein; S E Moss
Journal:  Ophthalmology       Date:  1985-09       Impact factor: 12.079

6.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12

7.  Extracapsular cataract extraction with placement of a posterior chamber lens in patients with diabetic retinopathy.

Authors:  W E Benson; G C Brown; W Tasman; J A McNamara; J F Vander
Journal:  Ophthalmology       Date:  1993-05       Impact factor: 12.079

8.  Prevalence of cataract and pseudophakia/aphakia among adults in the United States.

Authors:  Nathan Congdon; Johannes R Vingerling; Barbara E K Klein; Sheila West; David S Friedman; John Kempen; Benita O'Colmain; Suh-Yuh Wu; Hugh R Taylor
Journal:  Arch Ophthalmol       Date:  2004-04

9.  Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation.

Authors:  G J Jaffe; T C Burton; E Kuhn; A Prescott; A Hartz
Journal:  Am J Ophthalmol       Date:  1992-10-15       Impact factor: 5.258

10.  Course of diabetic retinopathy following cataract surgery.

Authors:  A Pollack; S Dotan; M Oliver
Journal:  Br J Ophthalmol       Date:  1991-01       Impact factor: 4.638

View more
  20 in total

1.  Cost-Effectiveness of Preoperative OCT in Cataract Evaluation for Multifocal Intraocular Lens.

Authors:  Ella H Leung; Allister Gibbons; Douglas D Koch
Journal:  Ophthalmology       Date:  2020-01-31       Impact factor: 12.079

2.  Macular edema after cataract surgery in diabetic eyes evaluated by optical coherence tomography.

Authors:  Xiao-Yong Chen; Wen-Jun Song; Hong-Yuan Cai; Lin Zhao
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

3.  Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants.

Authors:  Y Yang; C Bailey; F G Holz; N Eter; M Weber; C Baker; S Kiss; U Menchini; J M Ruiz Moreno; P Dugel; A Lotery
Journal:  Eye (Lond)       Date:  2015-06-26       Impact factor: 3.775

4.  Visual Acuity, Retinal Sensitivity, and Macular Thickness Changes in Diabetic Patients without Diabetic Retinopathy after Cataract Surgery.

Authors:  Spela Stunf Pukl; Nataša Vidović Valentinčič; Mojca Urbančič; Irena Irman Grčar; Rok Grčar; Vladimir Pfeifer; Mojca Globočnik Petrovič
Journal:  J Diabetes Res       Date:  2017-01-24       Impact factor: 4.011

5.  EFFECT OF AN INTRAVITREAL DEXAMETHASONE IMPLANT ON DIABETIC MACULAR EDEMA AFTER CATARACT SURGERY.

Authors:  Pilar Calvo; Antonio Ferreras; Fadwa Al Adel; Wantanee Dangboon; Michael H Brent
Journal:  Retina       Date:  2018-03       Impact factor: 4.256

6.  Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies.

Authors:  Rishi P Singh; Giovanni Staurenghi; Ayala Pollack; Adeniyi Adewale; Thomas M Walker; Dana Sager; Robert Lehmann
Journal:  Clin Ophthalmol       Date:  2017-05-29

7.  Effect of topical nepafenac in prevention of macular edema after cataract surgery in patients with non-proliferative diabetic retinopathy.

Authors:  Muhammad Haroon Sarfraz; Rana Intisar Ul Haq; Mohammad Asim Mehboob
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

8.  Role of combined phacoemulsification and intravitreal injection of bevacizumab in prevention of postoperative macular edema in non-proliferative diabetic retinopathy.

Authors:  Alireza Khodabandeh; Shahed Fadaifard; Ali Abdollahi; Reza Karkhaneh; Ramak Roohipoor; Fatemeh Abdi; Hamed Ghasemi; Sam Habibollahi; Mehdi Mazloumi
Journal:  J Curr Ophthalmol       Date:  2018-05-11

Review 9.  Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.

Authors:  Ryan Lee; Tien Y Wong; Charumathi Sabanayagam
Journal:  Eye Vis (Lond)       Date:  2015-09-30

Review 10.  Cataract surgery in diabetes mellitus: A systematic review.

Authors:  Aditya Kelkar; Jai Kelkar; Hetal Mehta; Winfried Amoaku
Journal:  Indian J Ophthalmol       Date:  2018-10       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.